What is the current Crispr Therapeutics share price?
The current share price of Crispr Therapeutics is 64.6.
How many Crispr Therapeutics shares are in issue?
Crispr Therapeutics has 79,874,000 shares in issue.
What is the market cap of Crispr Therapeutics?
The market capitalisation of Crispr Therapeutics is USD 5.16 B.
What is the 1 year trading range for Crispr Therapeutics share price?
Crispr Therapeutics has traded in the range of US$ 64.60 to US$ 64.60 during the past year.
What is the PE ratio of Crispr Therapeutics?
The price to earnings ratio of Crispr Therapeutics is -22.76.
What is the cash to sales ratio of Crispr Therapeutics?
The cash to sales ratio of Crispr Therapeutics is 9.42.
What is the reporting currency for Crispr Therapeutics?
Crispr Therapeutics reports financial results in USD.
What is the latest annual turnover for Crispr Therapeutics?
The latest annual turnover of Crispr Therapeutics is USD 371.21M.
What is the latest annual profit for Crispr Therapeutics?
The latest annual profit of Crispr Therapeutics is USD -153.61M.
What is the registered address of Crispr Therapeutics?
The registered address for Crispr Therapeutics is BAARERSTRASSE 14, ZUG, 6300.
What is the Crispr Therapeutics website address?
The website address for Crispr Therapeutics is www.crisprtx.com.
Which industry sector does Crispr Therapeutics operate in?
Crispr Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector.
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
